Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

NCT02830477 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02830477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02830477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 14, 2016
Completion date
March 1, 2021
Enrollment
313 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a, congenital